AstraZeneca shares owned by Boston Common Asset Management
Quarter-by-quarter ownership of AstraZeneca shares owned by Boston Common Asset Management
from 13F filings
Historical chart of Boston Common Asset Management investment in AstraZeneca
Tip: Access up to 7 years of quarterly data
All positions including AstraZeneca held by Boston Common Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in AstraZeneca by Boston Common Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $7.7M | 83k | 91.93 |
| 2025-09-30 | $5.3M | 69k | 76.72 |
| 2025-06-30 | $4.8M | 69k | 69.88 |
| 2025-03-31 | $5.3M | 72k | 73.50 |
| 2024-12-31 | $3.6M | 55k | 65.52 |
| 2024-09-30 | $4.9M | 63k | 77.92 |
| 2024-06-30 | $5.2M | 66k | 77.99 |
| 2024-03-31 | $4.7M | 69k | 67.76 |
| 2023-12-31 | $4.5M | 68k | 67.35 |
| 2023-09-30 | $5.0M | 74k | 67.72 |
| 2023-06-30 | $5.4M | 76k | 71.56 |
| 2023-03-31 | $5.1M | 74k | 69.41 |
| 2022-12-31 | $4.5M | 66k | 67.80 |
| 2022-09-30 | $2.9M | 53k | 54.85 |
| 2022-06-30 | $2.6M | 39k | 66.07 |
More positions owned by Boston Common Asset Management
View all positions for Boston Common Asset Management